Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 26 citing articles:

A Prediction Model Based on Systemic Immune-Inflammatory Index Combined with Other Predictors for Major Adverse Cardiovascular Events in Acute Myocardial Infarction Patients
Xiaobo Li, Yu Chen, Xuewei Liu, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 1211-1225
Open Access | Times Cited: 11
The Role of Thrombo-inflammation in Ischemic Stroke: Focus on the Manipulation and Clinical Application
Yuanfei Luo, Weichen Dong, Linying Yuan, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 5
Platelet activation and endothelial dysfunction biomarkers in acute coronary syndrome: the impact of PCSK9 inhibition
Efthymios Ziogos, Stephen P. Chelko, Tarek Harb, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2023) Vol. 9, Iss. 7, pp. 636-646
Closed Access | Times Cited: 12
Circulating PCSK9 as a prognostic biomarker of cardiovascular events in individuals with type 2 diabetes: evidence from a 16.8-year follow-up study
Massimiliano Ruscica, Chiara Macchi, Angelica Giuliani, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 11
Role of PCSK9 inhibition during the inflammatory stage of SARS-COV-2: an updated review
Hina Arsh, FNU Manoj Kumar, FNU Simran, et al.
Annals of Medicine and Surgery (2024) Vol. 86, Iss. 2, pp. 899-908
Open Access | Times Cited: 4
The Effect of PCSK9 Monoclonal Antibodies on Platelet Reactivity and Cardiovascular Events in Patients Receiving Primary Percutaneous Coronary Intervention: A Propensity Score-Matched Analysis
Yao Yao, Qining Qiu, Zi Wang, et al.
American Journal of Cardiovascular Drugs (2025)
Closed Access
Effects of PCSK9 on thrombosis and haemostasis in a variety of metabolic states: Lipids and beyond (Review)
Shan Chong, Guangyan Mu, Xinan Cen, et al.
International Journal of Molecular Medicine (2024) Vol. 53, Iss. 6
Open Access | Times Cited: 3
The correlation between proprotein convertase subtilisin/kexin type 9 and adiponectin in the progression from prediabetes to type 2 diabetes mellitus
Jun-Xu Gu, Kun Wang, Aimin Zhang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Association between the neutrophil-to-lymphocyte ratio and risk of in-hospital heart failure and arrhythmia in patients with acute myocardial infarction
Jiali Zhang, Rui Yang, Yi Zhu, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 8
Targeting PCSK9 as a key player in lipid metabolism: exploiting the therapeutic and biosensing potential of aptamers
Maryam Mahjoubin‐Tehran, Samaneh Rezaei, Raúl D. Santos, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 2
The Anti-Thrombotic Effects of PCSK9 Inhibitors
Martin Jozef Péč, J Benko, Jakub Jurica, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 9, pp. 1197-1197
Open Access | Times Cited: 4
High-Fat Diet Enhances Platelet Activation and Is Associated with Proprotein Convertase Subtilisin Kexin 9: An Animal Study
Fadlina Chany Saputri, Nuriza Ulul Azmi, Meidi Utami Puteri, et al.
Nutrients (2023) Vol. 15, Iss. 20, pp. 4463-4463
Open Access | Times Cited: 4
Longitudinal change of serum exosomal miR-186-5p estimates major adverse cardiac events in acute myocardial infarction patients receiving percutaneous coronary intervention
Lingyun Ren, Wei Liu, Shanshan Chen, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 1
Inhibition of PCSK9 Protects against Cerebral Ischemia‒Reperfusion Injury via Attenuating Microcirculatory Dysfunction
Yuanfei Luo, Linying Yuan, Zhihui Liu, et al.
Neurochemical Research (2024) Vol. 50, Iss. 1
Closed Access | Times Cited: 1
Prognostic Impacts of LL-37 in Relation to Lipid Profiles of Patients with Myocardial Infarction: A Prospective Cohort Study
Runzhen Chen, Hanjun Zhao, Jinying Zhou, et al.
Biomolecules (2022) Vol. 12, Iss. 10, pp. 1482-1482
Open Access | Times Cited: 6
The effect of SGLT2i on in-hospital acute heart failure risk in acute myocardial infarction patients—a retrospective study
Yi Zhun Zhu, Jiali Zhang, Hong Jin, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 3
Insight into the role of PCSK9 in glucose metabolism
Jia-ni Xu, Tingting Wang, Hong Shu, et al.
Clinica Chimica Acta (2023) Vol. 547, pp. 117444-117444
Open Access | Times Cited: 2
Novel Low-Density Lipoprotein Cholesterol Reduction Therapies for the Secondary Prevention of Cardiovascular Disease
Xing Wang, Dingke Wen, Mei Fang, et al.
Reviews in Cardiovascular Medicine (2023) Vol. 24, Iss. 10, pp. 286-286
Open Access | Times Cited: 2
Clinical Significance of PCSK9 and Soluble P-selectin in Predicting Major Adverse Cardiovascular Events After Primary Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome
Yao Yao, Qining Qiu, Xiaoye Li, et al.
Cardiovascular Innovations and Applications (2024) Vol. 9, Iss. 1
Open Access
Evaluation of adropin indices and PCSK9 in non-diabetic men with severe obstructive sleep apnea
Levent Deniz, Hale Aral, Özlem Akdoğan, et al.
Turkish Journal of Biochemistry (2024) Vol. 49, Iss. 4, pp. 509-517
Open Access
Combining action research theory with focus-solving short-term psychotherapy for psychological stress, adjustment, and rehabilitation in patients with postoperative acute myocardial infarction following percutaneous coronary intervention
Jiaojiao Wang, Li Sun, Yuxi Li, et al.
American Journal of Translational Research (2024) Vol. 16, Iss. 7, pp. 2910-2920
Open Access
Percorso diagnostico e terapeutico della dislipidemia nel paziente ad alto rischio cardiovascolare
Elio Venturini, Giancarlo Casolo, Marco Comeglio, et al.
Gazzetta Medica Italiana Archivio per le Scienze Mediche (2024) Vol. 183, Iss. 6
Open Access
Predictive values of bilirubin for in-hospital adverse events in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention
Ying Chen, Cun-Fei Liu, De-Qun Guo, et al.
Clinics (2023) Vol. 78, pp. 100306-100306
Open Access | Times Cited: 1
Correlation between Carbonic Anhydrase Isozymes and the Evolution of Myocardial Infarction in Diabetic Patients
Sorina Magheru, Calin Magheru, Florin Maghiar, et al.
Biology (2022) Vol. 11, Iss. 8, pp. 1189-1189
Open Access | Times Cited: 1
Circulating PCSK9 as a prognostic biomarker of cardiovascular events in individuals with type 2 diabetes: evidence from a 16.8-year follow-up study
Massimiliano Ruscica, Chiara Macchi, Angelica Giuliani, et al.
Research Square (Research Square) (2023)
Open Access
Page 1 - Next Page

Scroll to top